KANZER STEVE H 4
4 · ADEONA PHARMACEUTICALS, INC. · Filed Jan 20, 2009
Insider Transaction Report
Form 4
KANZER STEVE H
DirectorChairman10% Owner
Transactions
- Expiration (Short)
Warrants
2009-01-14−373,639→ 0 total(indirect: By LLC)Exercise: $2.22From: 2006-11-28Exp: 2016-11-27→ Common Stock (373,639 underlying) - Expiration (Short)
Warrants
2009-01-14−832,606→ 0 total(indirect: By LLC)Exercise: $2.22From: 2006-10-31Exp: 2011-11-30→ Common Stock (832,606 underlying) - Expiration (Short)
Warrants
2009-01-14−7,651→ 0 total(indirect: By LLC)Exercise: $3.30From: 2007-01-05Exp: 2015-05-30→ Common Stock (7,651 underlying)
Holdings
- 7,086,380(indirect: By LLC)
Common Stock
- 271,058
Stock Options
Exercise: $2.01From: 2008-01-09Exp: 2016-10-30→ Common Stock (271,058 underlying) - 375,246
Common Stock
Footnotes (2)
- [F1]Received in exchange for shares of Pipex Therapeutics Inc. common stock upon the October 31, 2006 merger of Pipex Therapeutics, Inc. and a wholly owned subsidiary of the Registrant. Mr. Kanzer is the managing member of Pharmainvestors LLC, the managing member of Accredited Venture Capital, LLC.
- [F2]Received in exchange for shares of Pipex Therapeutics Inc. common stock upon the October 31, 2006 merger of Pipex Therapeutics, Inc. and a wholly owned subsidiary of the Registrant. Mr. Kanzer is the managing member of Pharmainvestors LLC, the managing member of Accredited Venture Capital, LLC. On January 14, 2009 Accredited Venture Capital LLC and the Registrant agreed to cancel the three sets of warrants held by Accredited Venture Capital LLC that in the aggregate were exercisable for 1,221,277 shares of the Registrant. The Registrant has agreed to register for resale the 7,086,379 shares of common stock held by Accredited Venture Capital LLC.